1-3 November 2023
University of Pretoria, Hatfield, South Africa.

Our Oximio teams in Africa and the UK will be heading to SACRA, in November.

One of the country’s most highly anticipated conferences this year, supporting clinical trials within South Africa and Sub Saharan Africa, it will provide a platform to gain valuable insights from industry stakeholders, explore revolutionary technologies, and connect with potential collaborators, colleagues, and industry leaders.

Attending from Oximio will be Rob van den Bergh, Managing Director of Oximio, Kenya; Paul van den Bergh, Managing Director of Oximio, South Africa and Mark Woolf, Chief Business Development Officer.

If you are attending and would like to arrange a time to talk to any of our team and find out how they are working to unlock the clinical trial potential of Africa, please contact us.